At Institute of Cancer Research, I developed a Nextflow targeted amplicon sequencing pipeline for circulating tumor DNA in metastatic breast cancer. I also integrated sequencing data to investigate markers and signatures associated with chemotherapy resistance.
During my Ph.D. at University of Oslo, I analyzed RNA-seq and ChIP-seq data to study AHR signaling in a breast cancer model. I’ve also developed deep learning models for TCGA cancer data and built OncoAgent, an LLM-assisted platform for reproducible cancer genomics analyses.

